IPI MEDIA INFORMATION 2015

MEDIA INFORMATION 2015

IPI is Peer Reviewed. Please refer to the Editorial

Guidelines section on the www.ipimediaworld.com

website for Peer Review Protocol and Authors

Guidelines.

Editorial topics listed are subject to changes, according

to the movement of the industry. We will be pleased to

hear from you if you have relevant topics you would like

to contribute within the journal.

Please email all your suggestions to:

[email protected]

http://www.ipimediaworld.com/

mailto:[email protected]

MEDIA INFORMATION

CONTACT [email protected] T + 44(0)207 2372036

The pharmaceutical industry is committed to the

research, development, quality manufacturing and

logistics of innovative medicines that save lives,

reduce overall health care costs and improve the

quality of life of people around the world.

The industry strives to create a global environment

that fosters: innovation in preventing and curing

diseases; drug regulation that expedites approvals of

new chemical and biological treatments for patients

and assures the availability of genuine quality

medicines; patient access to innovative therapies

and protection from substandard and counterfeit

products; market-based competition in the health

care sector; and, the dissemination of drug

information and ethical promotion of drugs to

medical professionals and, where legal, to patients.

IFPMA

In order to achieve this objective, it is essential for

the executives of this dynamic industry to constantly

keep themselves educated in the latest technology,

market information, regulatory and validatory

guidelines to gain a competitive edge.

Peer reviewed by our carefully selected editorial

advisory panel, and extensive research network, IPI

provides a proven supportive means of

communication to the pharmaceutical, bio

pharmaceutical, nutraceutical and medical devices

industry the latest in research and technology

innovations, regulatory guidelines, marketing and

communication strategies which will enable them to

be more efficient, bring products to market faster,

reduce cost and make healthcare accessible to all.

ipimediaworld.com

MEDIA INFORMATION


‘’’’

WHY CHOOSE IPI

87%

83.6% of our subscribers would be extremely or very

likely to refer IPI to a colleague or co - worker

ADVERTISERS PERSPECTIVE

89% Advertisers have repeated advertisements in IPI

85% Have utilised IPI Online services

81% Have advertised every consecutive year

62% Advertisers chose IPI above other industry publications

8% Have requested bespoke distribution

AUTHORS PERSPECTIVE

76%

61%

44%

29%

8.2%

Authors have submitted further articles

Have requested reprints

Had article downloaded from the website

Articles searched by name

Impact factor

READERS PERSPECTIVE

83%

81%

11%

62%

3.2%

Have renewed subscription year

on year

Have read the last 4 issues

Have kept copies for future reference

Subscribers correspond with authors

New subscription every year

90.7%

of IPI readers are involved in the decision of

purchasing products and services for their

company

of our subscribers read or look through IPI

within one week of receiving their copy

MEDIA INFORMATION


International Pharmaceutical Industry is a globally distributed

publication with an established presence across the world. Each

quarterly issue has a print copy distribution figure of

20,000 copies, providing strong access to the

International Market.

IPI is sent directly to key decision makers in the Life Sciences

Industry, addressing all stakeholders.

Europe 8,435

Americas 6,442

Asia 2,736

ROW 2,387

GEOGRAPHICAL PROFILE

Pharmaceutical/Bio-Pharmaceutical Companies 50.2%

Contract Manufacturing Companies 11.2%

Analytical & Biochemical Laboratories 8.0%

Contract Research Organisations (CRO) 7.1%

Fine Chemical Companies 7.0%

Contract Packers 6.5%

Health Services 6.0%

Others including Specialty Pharma, Drug Consultants, Financial Institutions & Governments 4.0%

CEO / CFO / CMO 9%

Heads of Operations 11%

Medical Directors 7%

Heads of Procurement 9%

Heads of Regulatory Affairs 5%

Heads of Production 8%

Heads of Formulation Development 8%

Heads of Clinical Trials 7%

Heads of Business Development, Brand Managers, Sales & Marketing 8%

Logistics & Supply Chain Managers 6%

Heads of Packaging Management 11%

Heads of Research & Development 11%

DISTRIBUTION BY JOB FUNCTION

INDUSTRY BREAKDOWN

CIRCULATION AND READERSHIP

MEDIA INFORMATION


RATES AND DATA International Pharmaceutical Industry provides print advertisements and a package of online services, dedicated to

assist you with your marketing campaigns.

Hard Copy Print Advertising Rates

Double Page £5,250

Full Page £2,850

Half Page (Vertical / Horizontal) £1,650

Prime Positions:

Inside Front Cover £5,950

Inside Back Cover £4,850

Outside Back Cover £7,250

Page Opposite Contents £3,750

Page Opposite Editor’s Letter £3,750

1 Page Corporate Profile £2,000

Front Cover LOGO £1,500

Book more than one insertion and the rates will be

discounted. Inserts, reprints and recruitment advertisers’

rates are available on application.

For more information contact: [email protected]

Mechanical Data

(In Millimeters, Height x Width, with Type, Trim, Bleed)

Type Trim Bleed

Full Page: 273 x 186 297 x 420 303 x 426

½ Page: 135 x 186 148 x 210 151 x 213

(Horizontal)

½ Page: 273 x 92 297 x 105 303 x 108

(Vertical)

Please supply digitally, ideally a press ready PDF.

Alternatively supply as a flat image file (Tiff, Jpeg, EPS,

PSD etc) ensuring that all fonts are embedded, images are

High-resolution and the file is CMYK

For Advertising Contact

Anthony Stewart

T: +44 (0) 207 2372036

Email: [email protected]

MEDIA INFORMATION


OUTSOURCING AND INNOVATIONS SUPPLEMENT

IPI supports the best practice in outsourcing management for the pharmaceutical and biopharmaceutical industry. In

line with this IPI creates an Outsourcing & Innovations Supplement, which runs through the months of September to

December. The supplement is distributed at a number of the industry’s best events, giving clients the chance of high

visibility.

Each Company receives 2 pages:

Left Hand Page – 600 – 650 words Company Profile

+ Logo and 2 Pictures]

Right Hand Page – A4 Advert

Rates:

Inside Front Cover Advert + 2 page Profile £2,500 net

Inside Back Cover + 2 Page Profile £2,000 net

Outside Back Cover + 2 Page Profile £3,000 net

Run of Paper (1 Page Profile + 1 Page advert) £1,500 net

Each Company will feature their LOGO on the Index Page, and 5

Company Key Features

MEDIA INFORMATION


720,326 page views

365,302 visits

206,762 unique visitors

76,400 returning visitors

1.59 page visit

00:01:45 average visit duration

ONLINE MEDIA INFORMATION

The location report from Google analytics (2013/2014) reveals that over 87% of visits came from Europe, America, Asia

and Middle East. The leading countries are United States, United Kingdom, Germany, France, Norway, Switzerland,

Italy, China, India, UAE, Saudi Arabia and Australia.

Google analytics report that 206,762 unique people visited IPI website at – www.ipimediaworld.com. Visitors were

involved in research & development, analytics, production, manufacturing, packaging, drug discovery, development,

delivery, formulation, regulatory affairs, intellectual property, laboratory, logistics & supply chain management, branding

& marketing.

288,902 new visits and 76,400 returning visitors spent an average of 00:01:45 on each visitation reading current article

from the IPI Journal, looking at company profiles, visiting banner adverts and reading current news.

365,302 visits to the site

www.ipimediaworld.com



MEDIA INFORMATION


ONLINE COMPANY PROFILE Lists your company, its contact details and key features of your company

Publish more information about your company, product information, product pictures or site pictures, events you

attend or job vacancies. Link them to various pages within your website.

First Page View

Company Profile View

Benefits Include:

Company news is published in the IPI eNewsletter and sent to more than 10,500 industry

professionals.

Full usage stats are available

Rates:

The price is £2,000 for a 12 month contract, equivalent to just £166 per month

MEDIA INFORMATION


ONLINE ADVERTISING Your banner will stay live for the length of the online booking and / or the duration of your print schedule.

Mast Head Banner

728 x 90 px

Rate: £900 per 3 months

Right Column Rectangle

Banner (Or Company LOGO)

300 x 250 px


Right Column Skyscraper

300 x 600 px


Right Column Rectangle

300 x 250 px


Left Column Skyscraper

300 x 600 px


Other Positions

Sponsored Articles:


Events Listing

Rate: £150 per months

Upload Your Video

£800 for 3 months and

thereafter £150 per

month

MEDIA INFORMATION


NEWSLETTERS IPI – Weekly eNewsletter provides the latest business

news, product news, events, technical papers, and

links to highlighted articles from the latest issue of IPI.

This gives you the regular and latest update on the

global pharmaceutical and biopharma development

and manufacturing communities.

IPI eNewsletter is sent to more than 10,500

professionals working for the leading companies

involved in drug discovery and development,

pharmaceutical manufacturing, and bio-

pharmaceutical companies.

CONTACT Pharma Publications

Unit J, 413

Tower Bridge Business Complex

100 Clements Road

London – SE16 4DG


International Media Director

Anthony Stewart

T: +44 (0) 207 2372036


Editor:

Cecilia Stroe

T: +44 (0) 207 2372036


Editorial Manager

Orsolya Balogh

T: +44 (0) 207 2372036


Subscriptions:

Martin Wright

T: +44 (0) 207 2372036


General Enquiries:

T: +44 (0) 207 2372036



Rates:

Recruitment

£60 per week

Banner Advert

£80 per week

Company News

£90 per week






MEDIA INFORMATION


IPI EDITORIAL CALENDAR 2015

IPI – International Pharmaceutical Industry is peer reviewed. Supported by a team of industry experts, IPI brings you

contemporary and authoritative articles which will guide the industry in the best practice in regulatory issues, market

analysis, drug discovery, development, delivery methods, clinical research, laboratories, analytical testing, custom and

contract manufacturing, primary and secondary packaging and logistics and supply chain management.

Please visit our website www.ipimediaworld.com, to view our Peer review protocol, and author guidelines.

EDITORIAL SECTIONS

Regulatory and Marketplace Drug Discovery, Development

& Delivery

Clinical & Medical Research Laboratories

Logistics & Supply Chain Manufacturing

Management

Packaging Information Technology


.

Manufacturing

> Parenteral > Semi Solids / Creams & Ointments

> Neutraceuticals > Topical

> IV Drug Delivery > Robotics & CAM

> Filtration & Separation > Prefilled Injectable

> Inhalation > PAT & Quality by Design

Regulatory & Marketplace

> FDA Inspection & Validation > Health Economics

> Patent Law > Insurance

> Epidemiology & Drug Discovery

Drug Discovery / Development & Delivery

> Toxicity Assays > Inhalation & Nasal Drug Delivery – MDI’s & DPI’s

> Diabetes > Advances in Stem Cell Technology

> Imaging Technologies (Safety & Testing) > Cardiovascular / Metabolic

> Biopharmaceutical Lab Services > Supporting Drug Safety

> Analytical Testing

Clinical & Medical Research

> Ethics Committee & Review Boards > Adaptive Clinical Trials – Personalised Medicine

> Biomarkers > Clinical Patient Recruitment

> Data Management > Late Stage Research (Phase II – IV)

Clinical Trials

> Patient Recruitment & Retention > Adaptive Clinical Trials

> CTS / CTMS > Pharmacokinetics (PK Studies)

> Biodynamic > Named Patient Programme

> Therapeutic Vaccine

Laboratories

> Imaging & Data Collection

Logistics & Supply Chain Management

> IVRS / IWRS / IXRS > E – Procurement

> Hazardous Cargo > Temperature Controlled Supply Chain

> CT Supply Chain Logistics

Packaging

> Patient Adherence Packaging > Braille Packaging

> Child resistant & Senior Friendly > Sterile Packaging / Sterile Closures

> IV Bags & Delivery Systems > Moisture Barrier

Exhibitions & Conferences Attended by IPI with this issue:

> DIA Euro Meeting 2015 > Interphex (New York) > BIO Trinity 2015

> 12th Anglo Nordic BioTech conference > 24th Partnership in Clinical Trials (USA) > BIO Europe Spring (Paris)

> SMi – Control Release – 2015 > Pharma Supply Chain > Latin America / Cold Chain

> Pharma Traceability (IQPC Conference) > RDD Online Europe (Nice) > BIO Pharma Asia Convention

2015 > Clinical Trials Supply Chain Logistics (London)

Volume 7 Issue 1 – February 2015

Submission Deadline – 5th January 2015


> 51st DIA Annual Meeting > BIO USA (Philadelphia)

> 3rd BioLogistics Summit (San Francisco) > 12th EPIC (European Partnering & Investment Conference)


> Intellectual Property & Patent Law > Pharmacovigilance / Legislation

> Clinic to Commercialization > Quality Assurance / Quality Control

> Child resistant packaging policies > Audience Segmentation: Personalized Marketing


> Antibody Drugs for Oncology > Molecular Technology

> Parenteral > Nano Technology

> Custom Antibodies > Drug Implants

> In vivo / In vitro > Women’s Health

> Prefilled Injection Systems > Tableting (New Tablet Press generation)


> Preclinical > PK / PD Studies

> Imaging Technology > EDC / ePRO

> IVRS / IWRS / IXRS > Physician Liability & Ethics Review

> Phase 1 / Early Stage > Cancer / Immunotherapy (Development of Monoclonal

Antibodies)

Clinical Trials

> Managing Adverse Reactions > eClinical Solutions

> Patient Safety & Clinical Monitoring > CDISC

> Comparator Drug Supply > Phase 1 Clinical Trials

Laboratories

> Imaging, ECG & Core Labs > LIMS

> CAP Accreditation > Analytical Labs & Testing

> Margins & Operating Efficiencies


> Temperature Controlled Logistics > Cool / Cold Chain

> Supply Chain Security & Brand Protection

Manufacturing

> Leak Detection & Vision System > Quality Control & Quality Assurance

> FDA & EMEA Facility Compliance > Environmental Protection & Facility Management

> Solid Dosage Form production > Raman Spectroscopy

> Filtration & Milling > Blending & Mixing Technologies

Packaging

> Liquids & Sachets > Blistering & De-Blistering Machines

> Brand Protection > Sterile Fill Finish

> Prefilled Injection Systems > RFID Coding & Marking

> Clinical Trials Packaging

Volume 7 Issue 2 – May 2015

Submission Deadline – 25th March 2015


> Quality Assurance / Quality Control > Market Entry & Authorisation

> FDA Bio Research Monitoring > Programme – Protecting Human Subjects

> FDA/EMA / WHO – Validation & Accreditation > Intellectual Property

> Insurance & Liabilities


> Improving Antibody Efficacy > Oral Drug Delivery

> Stem Cells in Therapeutics > Formulation & Excipients

> Fragment Based Drug Design > Pulmonary Drug Delivery

> Injectable Pens & Self Injection > Biologics & Therapeutics

> Smart Pill technology


> Medical Imaging > eCTD

> Bio Equivalence Studies > Medical Devices

> SMO/ Site Management > Pharmacovigilance & Drug Safety

> Human Embryonic Stem Cells (hESCo)

Clinical Trials

> Cardiovascular Safety / QTC Prolongation > CTS/CTMS

> Rescue Studies > CDISC/CDASH

> Hepatic & Renal Impairment > Targeted Populations

Laboratories

> Global Central Laboratories > Cardiology

> Optical Sensing > Analytical Testing


> Safety Testing > Time Sensitive Shipment

> RFID Tracking Systems > Thermal Packaging / Insulated Shipping

> Emerging Markets Customs

Manufacturing

> Pre Filled Syringes / Self Injections > Active Ingredients & Fine Chemicals

> Ingredients & Intermediates > Sterile Fill Finish

> Blow Fill Seal Technology > Lyophilisation & Freeze Drying

> Containment Technology > TOC / HPLC

> Softgel Technology > the Suitability of Formulations

Packaging

> Labelling & Bar-coding > Patient Information Leafleting

> Translation & License Regulation > Electronic Notification & Intelligent Packaging

– To enhance patient compliance

> Booklet Labelling > Authentication & Brand Protection


> CPHI / ICSE / PMEC / BIOPH 2015 (Madrid) > BIO EUROPE – autumn

> Partnership in Clinical Trials Europe > Cold Chain Brazil

> 13th Annual Cold Chain GDP & Temp. Management

Logistics Forum (Boston)

Outsourcing

& Innovations

Supplement

(Contract Services)

Volume 7 Issue 3 – September 2015

Submission Deadline – 25th July 2015


> FDA / EMEA / WHO – > Helsinki Declaration –

> Validation & Accreditation what it means in the current climate.

> Vaccines & Adjuvant – Prevention & Cure > Cardiovascular Safety

> FDA/EMA Inspections


> Antibody Drugs for Oncology > Parenterals

> Cell Processing Tools > Fragment Based Drug Design

> Custom Antibodies > Transdermal

> Prefilled Injection Systems > CNS – Alzheimer’s

> Cognitive Research


> Managing Adverse Reactions > Phase I – IV

> Preclinical > PharmacoEconomics

> IMP Manufacturing & Supply > Medical Imaging

Clinical Trials

> Phase 1 Trials > Patient Recruitment & Retention

> Temperature Controlled / Data logging

In Clinical Trials Shipment

Laboratories

> Lab Validation > Imaging in Oncology

> LIMS


> Temperature Controlled/Data Logging > Tracking & Tracing

In Clinical Trials Shipment

Manufacturing

> Dosage Form Production > Lean Manufacturing / Six Sigma

Solids > PAT

Capsules > Tooling

> Aseptic Processing > Pure Water / WFI

> Clean Room & Contamination Control > Peptide Synthesis

> Pre-formulation > PAT & Quality by Design

Packaging

> Stability Testing & Shelf Life Management > Moisture Absorption & Moisture Barrier

> Anti-Counterfeiting & Brand Protection > RFID Coding & Marking

> Clinical Trials Packaging > Patient Information


> Genesis > Cold Chain Food Quality & Logistics Summit (Chicago)

> Pharmapack 2016 > Cool Chain Europe 2016

> Cold Chain Distribution

Volume 7 Issue 4 – November 2015

Submission Deadline – 25th September 2015

Pharma Publications

J413 Tower Bridge Business Complex

100 Clements Road

London – SE16 4DG

T: +44 (0) 207 2372036

E: [email protected]

W: www.ipimediaworld.com



IPI MEDIA INFORMATION 2015

Documents

Transcript of IPI MEDIA INFORMATION 2015